vs
Beam Therapeutics Inc.（BEAM）与Ranger Energy Services, Inc.（RNGR）财务数据对比。点击上方公司名可切换其他公司
Ranger Energy Services, Inc.的季度营收约是Beam Therapeutics Inc.的1.2倍（$142.2M vs $114.1M），Beam Therapeutics Inc.净利率更高（214.1% vs 2.3%，领先211.8%），Beam Therapeutics Inc.同比增速更快（279.5% vs -0.6%），Ranger Energy Services, Inc.自由现金流更多（$17.1M vs $-87.0M）
Beam Therapeutics是一家美国生物技术企业，专注于基因治疗与基因组编辑领域的研发，总部位于马萨诸塞州剑桥市。公司依托CRISPR碱基编辑和先导编辑技术，可通过酶促作用修改DNA序列中的单个核苷酸，且不会造成DNA双链断裂，以此开发相关治疗方案。
Ranger Energy Services是北美领先的陆上油田服务提供商，为上游油气运营商提供完井、修井、钻机作业及产能优化等全套解决方案，业务主要覆盖美国本土的页岩和致密资源开采作业区。
BEAM vs RNGR — 直观对比
营收规模更大
RNGR
是对方的1.2倍
$114.1M
营收增速更快
BEAM
高出280.1%
-0.6%
净利率更高
BEAM
高出211.8%
2.3%
自由现金流更多
RNGR
多$104.1M
$-87.0M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $114.1M | $142.2M |
| 净利润 | $244.3M | $3.2M |
| 毛利率 | — | — |
| 营业利润率 | -15.3% | 2.3% |
| 净利率 | 214.1% | 2.3% |
| 营收同比 | 279.5% | -0.6% |
| 净利润同比 | 370.4% | -44.8% |
| 每股收益（稀释后） | $2.53 | $0.14 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BEAMRNGR
| Q4 25 | $114.1M | $142.2M | ||
| Q3 25 | — | $128.9M | ||
| Q2 25 | — | $140.6M | ||
| Q1 25 | — | $135.2M | ||
| Q4 24 | — | $143.1M | ||
| Q3 24 | — | $153.0M | ||
| Q2 24 | — | $138.1M | ||
| Q1 24 | — | $136.9M |
净利润BEAMRNGR
| Q4 25 | $244.3M | $3.2M | ||
| Q3 25 | — | $1.2M | ||
| Q2 25 | — | $7.3M | ||
| Q1 25 | — | $600.0K | ||
| Q4 24 | — | $5.8M | ||
| Q3 24 | — | $8.7M | ||
| Q2 24 | — | $4.7M | ||
| Q1 24 | — | $-800.0K |
营业利润率BEAMRNGR
| Q4 25 | -15.3% | 2.3% | ||
| Q3 25 | — | 2.0% | ||
| Q2 25 | — | 6.1% | ||
| Q1 25 | — | 0.7% | ||
| Q4 24 | — | 6.2% | ||
| Q3 24 | — | 8.4% | ||
| Q2 24 | — | 5.3% | ||
| Q1 24 | — | -0.4% |
净利率BEAMRNGR
| Q4 25 | 214.1% | 2.3% | ||
| Q3 25 | — | 0.9% | ||
| Q2 25 | — | 5.2% | ||
| Q1 25 | — | 0.4% | ||
| Q4 24 | — | 4.1% | ||
| Q3 24 | — | 5.7% | ||
| Q2 24 | — | 3.4% | ||
| Q1 24 | — | -0.6% |
每股收益（稀释后）BEAMRNGR
| Q4 25 | $2.53 | $0.14 | ||
| Q3 25 | — | $0.05 | ||
| Q2 25 | — | $0.32 | ||
| Q1 25 | — | $0.03 | ||
| Q4 24 | — | $0.24 | ||
| Q3 24 | — | $0.39 | ||
| Q2 24 | — | $0.21 | ||
| Q1 24 | — | $-0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.2B | $10.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.2B | $300.1M |
| 总资产 | $1.5B | $419.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BEAMRNGR
| Q4 25 | $1.2B | $10.3M | ||
| Q3 25 | — | $45.2M | ||
| Q2 25 | — | $48.9M | ||
| Q1 25 | — | $40.3M | ||
| Q4 24 | — | $40.9M | ||
| Q3 24 | — | $14.8M | ||
| Q2 24 | — | $8.7M | ||
| Q1 24 | — | $11.1M |
总债务BEAMRNGR
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | $0 | ||
| Q2 24 | — | $0 | ||
| Q1 24 | — | $0 |
股东权益BEAMRNGR
| Q4 25 | $1.2B | $300.1M | ||
| Q3 25 | — | $270.0M | ||
| Q2 25 | — | $276.9M | ||
| Q1 25 | — | $272.6M | ||
| Q4 24 | — | $273.8M | ||
| Q3 24 | — | $267.6M | ||
| Q2 24 | — | $260.5M | ||
| Q1 24 | — | $261.7M |
总资产BEAMRNGR
| Q4 25 | $1.5B | $419.3M | ||
| Q3 25 | — | $372.8M | ||
| Q2 25 | — | $381.7M | ||
| Q1 25 | — | $376.5M | ||
| Q4 24 | — | $381.6M | ||
| Q3 24 | — | $373.9M | ||
| Q2 24 | — | $359.6M | ||
| Q1 24 | — | $355.5M |
负债/权益比BEAMRNGR
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.00× | ||
| Q1 24 | — | 0.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-83.3M | $24.1M |
| 自由现金流经营现金流 - 资本支出 | $-87.0M | $17.1M |
| 自由现金流率自由现金流/营收 | -76.3% | 12.0% |
| 资本支出强度资本支出/营收 | 3.3% | 4.9% |
| 现金转化率经营现金流/净利润 | -0.34× | 7.53× |
| 过去12个月自由现金流最近4个季度 | — | $42.9M |
8季度趋势，按日历期对齐
经营现金流BEAMRNGR
| Q4 25 | $-83.3M | $24.1M | ||
| Q3 25 | — | $13.6M | ||
| Q2 25 | — | $20.7M | ||
| Q1 25 | — | $10.6M | ||
| Q4 24 | — | $32.7M | ||
| Q3 24 | — | $17.7M | ||
| Q2 24 | — | $22.1M | ||
| Q1 24 | — | $12.0M |
自由现金流BEAMRNGR
| Q4 25 | $-87.0M | $17.1M | ||
| Q3 25 | — | $8.0M | ||
| Q2 25 | — | $14.4M | ||
| Q1 25 | — | $3.4M | ||
| Q4 24 | — | $27.3M | ||
| Q3 24 | — | $10.8M | ||
| Q2 24 | — | $6.8M | ||
| Q1 24 | — | $5.5M |
自由现金流率BEAMRNGR
| Q4 25 | -76.3% | 12.0% | ||
| Q3 25 | — | 6.2% | ||
| Q2 25 | — | 10.2% | ||
| Q1 25 | — | 2.5% | ||
| Q4 24 | — | 19.1% | ||
| Q3 24 | — | 7.1% | ||
| Q2 24 | — | 4.9% | ||
| Q1 24 | — | 4.0% |
资本支出强度BEAMRNGR
| Q4 25 | 3.3% | 4.9% | ||
| Q3 25 | — | 4.3% | ||
| Q2 25 | — | 4.5% | ||
| Q1 25 | — | 5.3% | ||
| Q4 24 | — | 3.8% | ||
| Q3 24 | — | 4.5% | ||
| Q2 24 | — | 11.1% | ||
| Q1 24 | — | 4.7% |
现金转化率BEAMRNGR
| Q4 25 | -0.34× | 7.53× | ||
| Q3 25 | — | 11.33× | ||
| Q2 25 | — | 2.84× | ||
| Q1 25 | — | 17.67× | ||
| Q4 24 | — | 5.64× | ||
| Q3 24 | — | 2.03× | ||
| Q2 24 | — | 4.70× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BEAM
| Pfizer | $109.1M | 96% |
| Other | $5.0M | 4% |
RNGR
| High Specification Rigs | $92.3M | 65% |
| Processing Solutions And Ancillary Services | $37.5M | 26% |
| Wireline Services | $12.4M | 9% |
